The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Open accessAbstract
Increasing antibiotic resistance in Gram-negative bacteria, particularly in Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae, presents a global medical challenge. No new antibiotics will be available for these 'superbugs' in the near future due to the dry antibiotic discovery pipeline. Colistin and polymyxin B are increasingly used as the last-line therapeutic options for treatment of infections caused by multidrug-resistant Gram-negative bacteria. This article surveys the significant progress over the last decade in understanding polymyxin chemistry, mechanisms of antibacterial activity and resistance, structure-activity relationships and pharmacokinetics/pharmacodynamics. In the 'Bad Bugs, No Drugs' era, we must pursue structure-activity relationship-based approaches to develop novel polymyxin-like lipopeptides targeting polymyxin-resistant Gram-negative 'superbugs'. Before new antibiotics become available, we must optimize the clinical use of polymyxins through the application of pharmacokinetic/pharmacodynamic principles, thereby minimizing the development of resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Self-citationLipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Self-citationMoffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Self-citationStructure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Self-citationGaronzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Self-citationGunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Self-citationPlachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Nation, R. L., & Li, J. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328332e672 · Cited by 443
Self-citationMcPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence
Padilla, E., Llobet, E., Doménech-Sánchez, A., Martínez-Martínez, L., Bengoechea, J. A., & Albertí, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00715-09 · Cited by 431
The bacterial outer membrane as a drug barrier
HANCOCK, R. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)81773-8 · Cited by 388
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Self-citationGales, A. C., Jones, R. N., & Sader, H. S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr239 · Cited by 337
Gunn, J. S. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.03.007 · Cited by 332
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
Arroyo, L. A., Herrera, C. M., Fernandez, L., Hankins, J. V., Trent, M. S., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00256-11 · Cited by 275
Macfarlane, E. L. A., Kwasnicka, A., Ochs, M. M., & Hancock, R. E. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01600.x · Cited by 254
Sampson, T. R., Liu, X., Schroeder, M. R., Kraft, C. S., Burd, E. M., & Weiss, D. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-12 · Cited by 205
Dudhani, R. V., Turnidge, J. D., Coulthard, K., Milne, R. W., Rayner, C. R., Li, J., & Nation, R. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01114-09 · Cited by 205
Self-citationPristovšek, P., & Kidrič, J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991031b · Cited by 185
Hengzhuang, W., Wu, H., Ciofu, O., Song, Z., & Høiby, N. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06486-11 · Cited by 185
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
Self-citationColistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy
Hawley, J. S., Murray, C. K., & Jorgensen, J. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-07 · Cited by 183
Henry, R., Vithanage, N., Harrison, P., Seemann, T., Coutts, S., Moffatt, J. H., Nation, R. L., Li, J., Harper, M., Adler, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05191-11 · Cited by 181
Self-citationDudhani, R. V., Turnidge, J. D., Nation, R. L., & Li, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq226 · Cited by 181
Self-citationBreazeale, S. D., Ribeiro, A. A., McClerren, A. L., & Raetz, C. R. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414265200 · Cited by 176
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Self-citationMatthaiou, D. K., Michalopoulos, A., Rafailidis, P. I., Karageorgopoulos, D. E., Papaioannou, V., Ntani, G., Samonis, G., & Falagas, M. E. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181652fae · Cited by 163
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., & Li, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.07.010 · Cited by 162
Self-citationGram-Negative Outer and Inner Membrane Models: Insertion of Cyclic Cationic Lipopeptides
Clausell, A., Garcia-Subirats, M., Pujol, M., Busquets, M. A., Rabanal, F., & Cajal, Y. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp064757+ · Cited by 159
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
Kubin, C. J., Ellman, T. M., Phadke, V., Haynes, L. J., Calfee, D. P., & Yin, M. T. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.01.015 · Cited by 158
Characterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Fernández, L., Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Kocíncová, D., Lam, J. S., Martínez, J. L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-12 · Cited by 155
Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L., & Li, J. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.11.002 · Cited by 152
Self-citationFernández, L., Jenssen, H., Bains, M., Wiegand, I., Gooderham, W. J., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01530-12 · Cited by 143
Bergen, P. J., Li, J., Nation, R. L., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm511 · Cited by 140
Self-citationTan, C.-H., Li, J., & Nation, R. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01571-06 · Cited by 138
Self-citationLoutet, S. A., Flannagan, R. S., Kooi, C., Sokol, P. A., & Valvano, M. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.6.2073-2080.2006 · Cited by 138
Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents
Vaara, M., Fox, J., Loidl, G., Siikanen, O., Apajalahti, J., Hansen, F., Frimodt‐Møller, N., Nagai, J., Takano, M., & Vaara, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00405-08 · Cited by 138
SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
Barnett, M., Bushby, S. R. M., & Wilkinson, S. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01610.x · Cited by 134
Llobet, E., Campos, M. A. L., Giménez, P., Moranta, D., & Bengoechea, J. A. (2011) · Infection and Immunity · doi:10.1128/iai.05226-11 · Cited by 125
Interactions of Lipopolysaccharide and Polymyxin Studied by NMR Spectroscopy
Mareš, J., Kumaran, S., Gobbo, M., & Zerbe, O. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806587200 · Cited by 116
Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia
Loutet, S. A., & Valvano, M. A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00159 · Cited by 116
Bergen, P. J., Forrest, A., Bulitta, J. B., Tsuji, B. T., Sidjabat, H. E., Paterson, D. L., Li, J., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05028-11 · Cited by 115
Self-citationKlebsiella pneumoniae OmpA Confers Resistance to Antimicrobial Peptides
Llobet, E., March, C., Giménez, P., & Bengoechea, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00657-08 · Cited by 103
N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity
Tsubery, H. (2001) · Peptides · doi:10.1016/s0196-9781(01)00503-4 · Cited by 82
Karvanen, M., Plachouras, D., Friberg, L. E., Paramythiotou, E., Papadomichelakis, E., Karaiskos, I., Tsangaris, I., Armaganidis, A., Cars, O., & Giamarellou, H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00985-12 · Cited by 82
Biochemistry and Physiology of Hopanoids in Bacteria
Sahm, H., Rohmer, M., Bringer‐Meyer, S., Sprenger, G. A., & Welle, R. (1993) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60100-9 · Cited by 81
Μάρκου, Ν., Fousteri, M., Markantonis, S. L., Zidianakis, B., Hroni, D., Boutzouka, E. G., & Baltopoulos, G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks257 · Cited by 68
Mogi, T., Murase, Y., Mori, M., Shiomi, K., Ōmura, S., Paranagama, M. P., & Kita, K. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp096 · Cited by 68
Warner, D. M., & Levy, S. B. (2009) · Microbiology · doi:10.1099/mic.0.033415-0 · Cited by 68
Malott, R. J., Steen, B. R., Lee, T. D., & Speert, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-11 · Cited by 62
Jiang, S.-S., Lin, T., Wang, W.-B., Liu, M.-C. J., Hsueh, P., & Liaw, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01384-09 · Cited by 62
Kimura, Y., Matsunaga, H., & Vaara, M. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.742 · Cited by 53
Removal of colistin during intermittent haemodialysis in two critically ill patients
Marchand, S., Frat, J., Petitpas, F., Lemaitre, F., Gobin, P., Robert, R., Mimoz, O., & Couet, W. R. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq185 · Cited by 51
Chihara, S., Ito, A., Yahata, M., Tobita, T., & Koyama, Y. (1974) · Agricultural and Biological Chemistry · doi:10.1271/bbb1961.38.521 · Cited by 49
Solid‐phase synthesis of polymyxin B1 and analogues via a safety‐catch approach
de Visser, P. C., Kriek, N. M. A. J., van Hooft, P. A. V., Schepdael, A. V., Filippov, D. V., van der Marel, G. A., Overkleeft, H. S., BOOM, J. H. V., & Noort, D. (2003) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2003.00061.x · Cited by 45
Quale, J. M., Shah, N., Kelly, P., Babu, E., Bäcker, M., Rosas-Garcia, G., Salamera, J., George, A., Bratu, S., & Landman, D. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0163 · Cited by 39
Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia
Loutet, S. A. (2011) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2011.00006 · Cited by 38
The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
Vaara, M. (1991) · PubMed · Cited by 34
Okimura, K., Ohki, K., Sato, Y., Ohnishi, K., & Sakura, N. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.1724 · Cited by 32
Loutet, S. A., Scott, J. B., Govan, J. R. W., Campopiano, D. J., & Valvano, M. A. (2009) · Microbiology · doi:10.1099/mic.0.027607-0 · Cited by 32
Cited by
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
El-Sayed Ahmed, M. A. E.-G., Zhong, L.-L., Shen, C., Yang, Y., Doi, Y., & Tian, G.-B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1754133 · Cited by 761
Unusual Amino Acids in Medicinal Chemistry
Blaskovich, M. A. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00319 · Cited by 635
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000020 · Cited by 421
Self-citationColistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Metadata
- Authors
- Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2013-05-23
- Volume
- 8
- Issue
- 6
- Pages
- 711-724
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2052899239
- Cited by
- 452
- References
- 74
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.